Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Arrowhead Pharmaceuticals- Inc. (ARWR)

16.35 0.05 (0.31%)

08-14 16:00

Open:

16.27

Pre. Close:

16.3

High:

16.99

Low:

16.25

Volume:

1,343,182

Market Cap:

1439M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

17.009 - 17.077

17.077 - 17.135

Low:

16.087 - 16.169

16.169 - 16.239

Close:

16.161 - 16.292

16.292 - 16.405

Technical analysis  (as of: 2018-08-14 4:26:45 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 20.44     One year: 23.87

Support:

Support1: 14.26    Support2: 12.25

Resistance:

Resistance1: 17.50    Resistance2: 20.44

Pivot:

15.70

Moving Averages:

MA(5): 16.42     MA(20): 15.88

MA(100): 11.25     MA(250): 7.18

MACD:

MACD(12,26): 0.41     Signal(12,26,9): 0.41

%K %D:

%K(14,3): 80.89     %D(3): 81.40

RSI:

RSI(14): 56.17

52-Week:

High: 17.5  Low: 1.9  Change(%): 749.0

Average Vol(K):

3-Month: 195932  10-Days 132349

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ARWR has closed below upper band by 35.4%. Bollinger Bands are 46.9% wider than normal. The large width of the bands suggest high volatility as compared to ARWR's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

2018-08-07T21:42:08-04:00
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Fiscal Q3 2018 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

88.02

Shares Float (M)

82.97

% Held by Insiders

5.80

% Held by Institutions

57.10

Shares Short (K)

13603

Shares Short Prior Month (K)

Stock Financials

EPS

-0.570

EPS Est. Current Year

-0.420

EPS Est. Next Year

-0.660

EPS Est. Next Quarter

-0.130

Forward EPS

-0.460

Book Value (p.s.)

14.530

PEG Ratio

-3.55

Profit Margin

Operating Margin

-404.51

Return on Assets (ttm)

-47.7

Return on Equity (ttm)

-56.6

Qtrly Rev. Growth

-92.2

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.247

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

Valuation

P/E

-28.60

P/E Growth Ratio

P/BV

1.12

P/S

8439667712.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2011-11-17

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.